R&D channel feed – Endpoints News

R&D channel feed

Lilly says tirzepatide kept obese and overweight people from developing diabetes

8 months ago

Walgreens nabs $100M BARDA partnership to expand decentralized clinical trials

8 months ago

BioNTech, MediLink to resume trial enrollment for HER3 antibody-drug conjugate after FDA pause

8 months ago

Q&A: Lilly’s top scientists on genetic medicine ambitions, and how they’re not just for rare diseases

8 months ago

Incyte plans label expansion for cancer drug Monjuvi following positive topline data

9 months ago

Pfizer, BioNTech review next steps as Covid and flu combo vaccine delivers mixed data

9 months ago

Updated: NIH says SIGA’s antiviral didn’t improve resolution in mpox lesions in the DRC

9 months ago

Zealand joins next-gen club aiming to ‘accelerate’ obesity drug development

9 months ago

Incyte gets another graft-versus-host disease drug approval, this time with partner Syndax

9 months ago

Arrowhead lays out early-stage obesity strategy, including new target on fat-storing cells

9 months ago

Sanofi backs AnaptysBio’s $100M offering, helping catapult the biotech’s stock

9 months ago

Verrica’s stock dips despite Phase 2 skin cancer drug clearing more than 50% of lesions

9 months ago

Metagenomi tinkers with pipeline after CSO departure, says Affini-T and Ionis pacts are progressing

9 months ago

Acelyrin sheds pipeline, lays off 33% of staff three months after CEO departure

9 months ago

Lilly opens huge new Boston research center, with a focus on genetic medicines

9 months ago

Rivus posts a win for its experimental obesity drug in heart failure patients

9 months ago

Exclusive: Gates Foundation backs startup using optogenetics to manufacture biologics

9 months ago

Corrected: Novo Nordisk to file in EU and China with late-phase insulin plus semaglutide data – but not yet in the US

9 months ago

Three papers on MDMA are retracted by medical journal, just a day after Lykos' FDA rejection

9 months ago

Pfizer touts strength of RSV vaccine in subgroup of younger immunocompromised patients

9 months ago

Amgen announces plans for new site in India to strengthen AI, data and life sciences

9 months ago

Genentech, Gilead push FDA to modernize research inspections

9 months ago

Autoimmune CAR-Ts are under the microscope after Cabaletta’s safety issue in lupus

9 months ago

Avidity CEO says it's ‘full steam ahead’ in DMD as stock rallies on Phase 1/2 win

9 months ago

First page Previous page 29 30 313233 34 35 Next page Last page